Click here for slides on this topic

Dopamine receptor agonists

A class of agents that activate post-synaptic dopamine receptors. Agents in this class may be used to treat type 2 diabetes, as well as hyperprolactinemia, acromegaly, and Parkinson’s Disease; refer to full prescribing information for indications and usage.
The following content matched the glossary term: Dopamine receptor agonists

Managing the Patient With Type 2 Diabetes and Heart Failure


.style1 FONT FAMILY Arial, Helvetica, sans serif COLOR #004685

ADA 2016 Type 2 Diabetes Pharmacologic Therapy


Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

AACE Diabetes Guidelines 2013


Diabetes management guidelines from the American Association of Clinical Endocrinologists (AACE)

ADA/European Association for the Study of Diabetes (EASD) Position Statement on Hyperglycemia Management in Type 2 Diabetes


Joint position statement from ADA/EASD with clinical practice recommendations for managing hyperglycemia in type 2 diabetes

Product Indications


Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).

Slide Library Results

Search Results for: Dopamine receptor agonists Slides Found: 0